Fresh IPO Debuts, Strong Subscription Demand And Inflation In Focus | What's Hot

In the latest "What's Hot" on Business Today Television, host Sakshi Batra discussed recent IPO listings with guest Sudeep Bandyopadhyay. Corona Remedies debuted strongly with a 36% premium, trading at ₹1,447 against its ₹1,062 issue price, reflecting solid fundamentals in pharma; investors advised to hold for further upside. Wakefit, however, listed flat and slipped 7% to ₹180.9 from ₹195, due to unproven expansion into home solutions and post-allotment selling.Upcoming healthcare IPOs: Positive long-term view on niche player Nefrocare, but suggest waiting post-listing; advise skipping Park MediWorld amid competition.Broader markets face time correction near 26,000, lacking triggers like US-India trade deal, with FII holdings at lows. Rupee hit record low at 90.63; RBI allowing depreciation for export competitiveness. Favor IT, two-wheelers (e.g., Bajaj, TVS), and autos showing green shoots from GST cuts. Cautious on aviation leader IndiGo due to potential market share erosion. Overall, stay invested in quality equities for 15%+ returns amid India's 7-8% GDP growth.